The bio-absorbable stent market has experienced significant advancements driven by innovative materials and precision manufacturing. The latest technologies, such as drug-eluting bioresorbable stents, use polymers such as polylactic acid (PLA) for controlled drug release to prevent restenosis. Advanced imaging techniques, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), are enhancing stent placement accuracy and monitoring.
3D printing has revolutionized stent prototyping, enabling customized designs that optimize biodegradability and mechanical strength. Moreover, hybrid bioresorbable stents incorporating magnesium alloys provide better radial support and rapid absorption. AI-driven analytics are utilized for patient-specific stent selection and procedural planning, enhancing outcomes.
The usage of bio-absorbable stents is growing due to their ability to minimize long-term complications, such as inflammation and thrombosis, compared to traditional metal stents. They are increasingly employed in treating coronary artery disease, particularly in younger patients, to restore natural vascular function post-absorption.
Market growth is fueled by rising cardiovascular disease prevalence, technological advancements, and government initiatives supporting minimally invasive solutions. Emerging markets, particularly in Asia-Pacific, present lucrative opportunities due to increasing healthcare investments and patient awareness.
